Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon.
The vaccine made by Pfizer and its German partner BioNTech already is available for anyone 12 and older. But with kids now back in school and the extra-contagious delta variant causing a huge jump in pediatric infections, many parents are anxiously awaiting vaccinations for their younger children.
“Over the past nine months, hundreds of millions of people ages 12 and older from around the world have received our COVID-19 vaccine. We are eager to extend the protection afforded by the vaccine to this younger population, subject to regulatory authorization, especially as we track the spread of the Delta variant and the substantial threat it poses to children,” said Pfizer CEO Albert Bourla.
For elementary school-aged kids, Pfizer tested a much lower dose — a third of the amount that’s in each shot given now. Yet after their second dose, children ages 5 to 11 developed coronavirus-fighting antibody levels just as strong as teenagers and young adults, Dr. Bill Gruber, a Pfizer senior vice president, told The Associated Press.
- Inside the January 6th Setup– Who is Ray Epps?
- Justin Trudeau Says That Unvaccinated People Are Usually ‘Racist’ And ‘Misogynist’.
- SCOTUS Ruling on OSHA mandate expected today
- Wait. What? Pfizer CEO now says 2 COVID shots “offers very limited protection, if any,” against COVID-19.
- BREAKING: Biden Administration Making Lists of Religious Vaccine Objectors
- Professor Absolutely Loses it on Zoom. (NSFW) “You are all just vectors of disease to me!”
- Rumors Persist Among Vatican Insiders That Pope Is Seriously Ill
- Another Soccer Star Dies of Heart Attack on Field!
- On Eve of Her Death, Comcast Exec Calls Ashli Babbitt a White Trash Insurrectionist Traitor
- Savage Dad Berates ‘Beta’ School Board With Perfect Comedic Timing